Syneron secondary offering priced at $28 per share

Lehman Brothers and CIBC World Markets acted as joint book-running managers of the offering.

Syneron Medical Ltd. (Nasdaq: ELOS) today announced that it priced the offering of 7,000,000 of its ordinary shares being sold by selling shareholders at $28 per share.

The selling shareholders have granted the underwriters a 30-day option to purchase up to an additional 1,050,000 of their ordinary shares.

Lehman Brothers Inc. and CIBC World Markets Corp. acted as joint book-running managers of the offering with Citigroup Global Markets Inc. serving as a joint lead manager. Stephens Inc., Thomas Weisel Partners LLC, and C.E. Unterberg, Towbin LLC acted as co-managers.

Published by Globes [online], Israel business news - www.globes.co.il - on Wednesday, March 09, 2005

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018